{
    "nct_id": "NCT05213936",
    "official_title": "Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color: A Clinical and Mechanistic Study",
    "inclusion_criteria": "1. Age >= 18 years\n2. Female\n3. Hair type 3 (curly) or type 4 (kinky)\n4. Diagnosis of breast cancer or non-small cell lung cancer (NSCLC) or gynecologic cancer stage I-IV\n5. Patient will be starting >= 4 cycles of taxane-based chemotherapy treatment for curative intent after enrollment\n\n   a. Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed\n6. Eastern Cooperative Oncology Group (ECOG) 0-2: fully active, restrictive in physically strenuous activity, ambulatory and capable of self-care\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Hair type other than 3 or 4\n2. Male\n3. Use of hair weave or extensions without plans to remove\n4. Concurrent malignancy including hematologic malignancies (i.e. leukemia or lymphoma)\n5. Alopecia Common Terminology Criteria for Adverse Events > grade 1 at baseline\n6. Past chemotherapy administration if past treatment was <= 10 years ago\n7. History of migraines or cluster headaches, anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid dysfunction, cold urticaria, cold agglutinin disease, scalp metastases\n8. Planned bone marrow ablation chemotherapy or skull irradiation\n9. Pregnant patient",
    "miscellaneous_criteria": ""
}